期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 114, 期 1, 页码 115-118出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.10064SC
关键词
angiotensin II-receptor blocker; transporter; uric acid
资金
- Japan Society for the Promotion of Science
- Gout Research Foundation of Japan
Hyperuricemia is currently recognized as a risk factor for cardiovascular diseases. It has been reported that the angiotensin II-receptor blocker (ARB) losartan decreases serum uric acid level. In this study, the effects of another ARB, irbesartan, on [C-14]uric acid-transport activity of renal uric acid reabsorptive transporters URAT1 and URATV1 were examined with Xenopus oocytes expressing each transporter. The results showed that irbesartan (100 - 500 mu M) inhibited the uptake of uric acid via both transporters. The inhibitory effects of irbesartan exceeded those of losartan and other ARBs, and the results suggest that irbesartan can reduce serum uric acid level.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据